Aura 2016 Supplementary data

Table S4.20 Neisseria meningitidis resistance to penicillin (MIC ≥1 mg/L), by jurisdiction, 2002–12

Year	Number of isolates	State or territory of isolation
2002	2	NSW and NT
2003	1	ACT
2004	1	NT
2005	1	NSW
2006	0	na
2007	0	na
2008	0	na
2009	0	na
2010	1	Vic
2011	1	Vic
2012	1	NSW

ACT = Australian Capital Territory; MIC = minimum inhibitory concentration; na = not applicable; NSW = New South Wales; NT = Northern Territory; Vic = Victoria

Note: All isolates had MIC = 1 mg/L.

Source: NNN (Australian Meningococcal Surveillance Programme annual reports)

Table S4.21 Neisseria meningitidis resistance to rifampicin (MIC ≥1 mg/L), by jurisdiction, 2001–14

Year	Number of isolates	State or territory of isolation
2001	4	Qld (3 with MIC = 1 mg/L;1 with MIC = 128 mg/L)
2002	0	na
2003	3	SA (MIC = 32 mg/L), Qld (MIC = 1 mg/L), WA (MIC = 100 mg/L)
2004	0	na
2005	1	Qld (MIC = 1 mg/L)
2006	1	Qld (MIC = 1 mg/L)
2007	3	Qld (MIC = 1 mg/L)
2008	1	Qld (MIC = 1 mg/L)
2009	0	na
2010	0	na
2011	0	na
2012	0	na
2013	0	na
2014	2	WA (1 with MIC = 4 mg/L; 1 with MIC = 16 mg/L)

MIC = minimum inhibitory concentration; na = not applicable; Qld = Queensland; SA = South Australia; WA = Western Australia

Source: NNN (Australian Meningococcal Surveillance Programme annual reports)

Table S4.22 Pseudomonas aeruginosa resistance (all specimen sources), 2014

Antimicrobial	% resistant	No. isolates tested
Ampicillin	100.0	12 207
Piperacillin–tazobactam	10.3	9 101
Cefazolin	100.0	6 692
Ceftazidime	4.5	21 387
Gentamicin	5.3	21 498
Ciprofloxacin	6.7	15 694
Meropenem	4.0	15 845
Trimethoprim–sulfamethoxazole	99.6	6 683

Sources: OrgTRx (Queensland); SNP (Queensland and northern New South Wales)